| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1151.17 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.17/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17 |
| Version | 20170216 |
| Status | active |
| Date | 2017-02-16T01:00:02-05:00 |
| Name | HighGradeBladderCancerTaForUrologyCare |
| Title | High grade bladder cancer Ta for Urology Care |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The high grade delineation is for the Primary Tumor (t) as related to bladder cancer. This is a noninvasive papillary carcinoma.),(Data Element Scope: The intent of this data element is to identify patients with high grade Ta bladder cancer which is non muscle invasive.),(Inclusion Criteria: High grade Ta nonmuscle invasive bladder cancer.),(Exclusion Criteria: Any Primary Tumor (T) stage other than Ta or low grade Ta.) |
No resources found
| CodeSystem | |
| sct | SNOMED CT (all versions) |
No narrative content found in resource
FHIR{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1151.17",
"meta": {
"versionId": "3",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Oregon Urology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-02-08"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2017-02-16"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1151.17"
}
],
"version": "20170216",
"name": "HighGradeBladderCancerTaForUrologyCare",
"title": "High grade bladder cancer Ta for Urology Care",
"status": "active",
"experimental": false,
"date": "2017-02-16T01:00:02-05:00",
"publisher": "Oregon Urology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The high grade delineation is for the Primary Tumor (t) as related to bladder cancer. This is a noninvasive papillary carcinoma.),(Data Element Scope: The intent of this data element is to identify patients with high grade Ta bladder cancer which is non muscle invasive.),(Inclusion Criteria: High grade Ta nonmuscle invasive bladder cancer.),(Exclusion Criteria: Any Primary Tumor (T) stage other than Ta or low grade Ta.)",
"compose": {
"include": [
{
"system": "http://snomed.info/sct",
"concept": [
{
"code": "371469007",
"display": "Histologic grade (observable entity)"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:894968bf-a56b-41fe-8b94-298695d06aec",
"timestamp": "2025-05-23T18:58:19-04:00",
"total": 1,
"contains": [
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/731000124108/version/20250301",
"code": "371469007",
"display": "Histologic grade of neoplasm (observable entity)"
}
]
}
}